Big Pharma
Head of Business Development, Search & Evaluation or External Innovation for Neuroscience.
This forum offers the opportunity for:
- Evaluation and comparison of related assets, pipelines and platforms
- Understanding of relevant scientific context to validate innovations and support strategic decision-making
- A boutique touchpoint for follow-up outside of JPM and BIO, with more time to give detailed guidance and feedback
“I liked the format it meant the companies knew what Sanofi was looking for and made the 30-minute meetings very efficient.” Sanofi, Neuroscience Innovation Partnering & Licensing Summit 2025
Biotech
Founders, C-Suite, Heads of Business Development Ensuring relevant exposure, biotech join this different format to:
- Network more efficiently with less competition to engage with key stakeholders
- Understand positioning and pitches of competitors to sharpen own differentiation
- Gain multiple 1-2-1 meetings for feedback on data packages to action ahead of BIO or other conferences later in the year
“The event assembled a diverse set of stakeholders extremely relevant for partnering in this specific field. It was the right size, meaning organic opportunities for connections” CEO, Neuroscience Innovation Partnering & Licensing Summit 2025
Investors
Corporate Venture & Venture Capital Connecting investors to both pharma and biotech teams, this unique opportunity allows investors to:
- Understand pharma’s reception to innovation developed by leading biotech to inform portfolio direction and exit strategies
- Efficiently gain landscape updates and information from private biotech
“The high seniority and high quality of participants made it easier than usual to get a meeting with the right people, primarily pharma.” Investor, Neuroscience Innovation Partnering & Licesning Summit 2025
Attending Companies Include